Formulation Development of Solid Self-Nanoemulsifying Drug Delivery Systems of Quetiapine Fumarate via Hot-Melt Extrusion Technology: Optimization Using Central Composite Design
Quetiapine fumarate (QTF) was approved for the treatment of schizophrenia and acute manic episodes. QTF can also be used as an adjunctive treatment for major depressive disorders. QTF oral bioavailability is limited due to its poor aqueous solubility and pre-systemic metabolism. The objective of the...
Main Authors: | Prateek Uttreja, Ahmed Adel Ali Youssef, Indrajeet Karnik, Kavish Sanil, Nagarjuna Narala, Honghe Wang, Rasha M. Elkanayati, Sateesh Kumar Vemula, Michael A. Repka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/16/3/324 |
Similar Items
-
Electrochemical Studies for the Determination of Quetiapine Fumarate and Olanzapine Antipsychotic Drugs
by: Manal A. El-Shal
Published: (2013-08-01) -
Quetiapine-Induced Severe Hypoglycemia in Patient Without Diabetes Mellitus: A Case Report
by: Suk Ju Cho, et al.
Published: (2019-03-01) -
Pharmacokinetic evaluation of quetiapine fumarate controlled release hybrid hydrogel: a healthier treatment of schizophrenia
by: Muhammad Akhlaq, et al.
Published: (2018-01-01) -
Brain Targeting of Quetiapine Fumarate via Intranasal Delivery of Loaded Lipospheres: Fabrication, In-Vitro Evaluation, Optimization, and In-Vivo Assessment
by: Randa Mohammed Zaki, et al.
Published: (2022-08-01) -
TITRIMETRIC AND SENSITIVE SPECTRO-PHOTOMETRIC METHODS FOR THE ASSAY OF QUETIAPINE FUMARATE IN PHARMACEUTICAL FORMULATIONS
by: Nagaraju Rajendraprasad, et al.
Published: (2011-03-01)